Skip to content

Lifestyle Management of Weight and Heart Disease Risk Factors in General Practice Patients

Piloting a structured comprehensive lifestyle program ,CLIP ,delivered via telephone on weight loss and lipid profile in overweight and obese general practice patients.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000341022
Enrollment
60
Registered
2010-04-28
Start date
2010-04-27
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

The CLIP handbook will be posted to the participant ,plus telephone coaching will be provided by the National Heart Foundation Healthy Heart Information call centre staff alongside usual general practitioner (GP)care.The coaching and introduction for each participant will take approximately 20 or 30 minutes. They will be contacted by a CLIP trained coach for an introduction to the program and will be subsequently supported by them by telephone every 2 weeks for 12 weeks.

Sponsors

Commonwealth Scientific Industrial Research Organisation
Lead SponsorGovernment body

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Prevention
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
30 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

Age 30-55 years, Body Mass Index between 26 and 40 kg/m2 or a waist circumference greater than 102cm for men and greater than 88cm for women.Have at least one additional cardiovascular or diabetes risk factor including family history of cardiovascular disease or type 2 diabetes, family history of premature heart disease or hypercholesterolemia. Walk independently and able to perform physical activity without pain. No personal history of cardiac abnormalities. Contactable by telephone Able to tolerate particular foods such as fish and whole grains.

Exclusion criteria

Reported medical treatment which GP indicates necessitates preclusion from study.Type 1 Diabetes .Lipid lowering medication ,for example Lipitor or Zocor. Concurrent use of medications which may be adversely affected by the intervention for example Warfarin. Existing chronic diseases like diabetes, ischemic heart disease and asthma. Women who are pregnant or breastfeeding Patients who have a terminal illness ,cancer. Patients deemed by their GP as not able to comply with the requirements of the study.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026